Delivery Order SPE2DB20D3103-SPE2DB24FQ2L4

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,578 firm-fixed-price contract is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $4,690.56 contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of February 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,799.40, is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 18, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,265.08, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,437.33, is for the supply of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 10, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,052.00 and a completion date of May 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,269.34, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,446.11 firm-fixed-price contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a completion date of September 18, 2024 and was awarded on September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, at a ceiling value of $2,395.14. The contract has an ultimate completion date of March 26, 2025 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a total ceiling value of $1,632.54. The contract has a completion date of June 16, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ2L4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,565.68, is for the delivery of the specialty medication MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed-price pricing type and an ultimate completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not include any set-aside designation, indicating open competition.

Generated 2/27/25, 1:24 PM